Accenture to Drive Organon’s ERP Transformation with SAP on AWS – Inside SAP Magazine

Women’s health specialist Organon adds to the list of Accenture’s global customers that have embarked on a digital and experience transformation journey leveraging SAP on AWS.

In June 2021, Organon was officially listed on New York Stock Exchange following its spin-off from Merck & Co., a leading global biopharmaceutical company. The newly formed company which reached US$6.53 billion in sales in the past year has 9,000 employees worldwide, a strong portfolio of 60 women’s health products, and a market footprint in 140 countries. In Australia, Organon is comprised of 90 team members and is anticipated to grow rapidly.

Keeping pace with its strategic development as a stand-alone company and the first major global pharmaceutical company dedicated to women’s health at that, Organon is investing in modernising its systems and processes to ensure business continuity and growth. Accenture was selected to deliver the pharmaceutical firm’s Enterprise Resource Planning (ERP) transformation project harnessing the power of SAP S/4HANA on AWS and Accenture MyConcerto.

Sharing about the innovation partnership with Accenture, Davey Sehwani, VP IT account management at Organon, said:

“We are excited to be modernising technology, simplifying processes and supporting the flexible adoption of partners, and providing connected real-time data. By leveraging Accenture’s comprehensive delivery approach combined with their functional knowledge across finance, commercial, supply chain, and manufacturing we are putting in place a business operating model fit for the future.”

Modernising ERP with SAP on AWS

SAP on AWS has been the platform of choice–whether for SAPS/4HANA migration or AWS services innovation– for over 5,000 customers and partners of Accenture. AWS offers flexibility and extensive value on SAP investments through highly secured and extensive cloud infrastructure, over 200 AWS services, and SAP automation capabilities– ultimately delivering unmatched cloud experience for SAP customers. 

In partnership with Accenture, a long-standing SAP partner across various industries, Organon will be embarking on a modernisation project focussed on establishing an ERP technology with a cloud-based digital core to deliver enhanced patient and employee experiences. SAP S/4HANA will be deployed using AWS cloud hosting to help the organisation streamline systems and processes as well ad minimise disruption. The company will be able to scale and accelerate the implementation of SAP S/4HANA harnessing the jointly developed accelerators with AWS through Accenture AWS Business Group (AABG), a joint investment and global innovation accelerator network of Accenture and AWS.

Natalia Roberts, Accenture’s client account lead for Organon, explained:

“Organon is establishing a foundation that will be essential to its ability to continue to grow as a company and fulfill its promise to the various communities it serves, including patients and its employees. Blending technology with human ingenuity, we look forward to helping Organon embrace the power of change to create holistic value to drive growth.”

In addition to deploying SAP S/4HANA on AWS, Organon will also utilise Accenture myConcerto, an insight-driven, digitally integrated platform that harmonises SAP solutions and technologies with Accenture’s industry and functional expertise to amplify business results in the intelligent enterprise. Through the platform, the pharmaceutical company aims not only to recognise challenges and establish a transformation vision but also design roadmap development and change management to achieve greater business results. Implementing a standardised technology platform empowers Organon with real-time analytics to rapidly take action according to patients, customers, and employees’ needs.

“Organon is investing in a modern and digital ERP core which will enable the next generation enterprise capabilities including analytics, automation, and cloud. We are honored to support Organon in this journey to fuel their growth and innovation,” commented Steen Moller, Accenture’s Global SAP Life Sciences Industry Lead.